Antiplatelet Agents

Known as: Drugs, Antiplatelet, drugs antiplatelet, Agents, Antiplatelet 
An agent that inhibits platelet aggregation and reduces coagulation in the circulatory system.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND The Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial showed that dabigatran etexilate 150 mg… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
With the increasing use of antiplatelet agents (APA), their management during the periendoscopic period has become a more common… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Anticoagulants are more effective than antiplatelet agents at reducing stroke risk in patients with atrial… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
CONTEXT Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Oral antiplatelet agents (OAAs) can prevent further vascular events in cardiovascular disease. How prior use or recent… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2004
Review
2004
Carlo Patrono (Chairperson)* (Italy), Fedor Bachmann (Switzerland), Colin Baigent (UK), Christopher Bode (Germany), Raffaele De… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 3
Is this relevant?
Review
1998
Review
1998
Aortocoronary saphenous vein graft disease, with its increasing clinical sequelae, presents an important and unresolved dilemma… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?